Fish Oil-based DHA Preparations for Children Market - Global Forecast 2026-2032

The Fish Oil-based DHA Preparations for Children Market size was estimated at USD 3.23 billion in 2025 and expected to reach USD 3.55 billion in 2026, at a CAGR of 9.52% to reach USD 6.11 billion by 2032.

The critical role of docosahexaenoic acid (DHA) in early neurological development has become increasingly recognized by global regulatory bodies and health experts alike. In 2014, the European Food Safety Authority affirmed that a daily intake of 100 milligrams of DHA contributes to normal brain development in infants and children, extending the scientific consensus that DHA supports neuronal growth and synaptogenesis throughout childhood. As dietary sources alone often fail to meet these requirements, fish oil–based DHA preparations have emerged as essential nutritional supplements to bridge this gap, ensuring adequate intake during the first two years of life and beyond.

The supply landscape for fish oil–derived DHA is witnessing unprecedented shifts driven by both demand and innovation. According to the marine ingredients organization IFFO, global fish oil production rose by 34% in the first quarter of 2025 compared with the same period a year earlier, reflecting expanded capacity in South America and select African markets. Concurrently, the approval of Bioplus Life Sciences’ algal DHA for infant formula by EFSA has accelerated the adoption of plant-based sources, offering a sustainable alternative that avoids overfishing while delivering equivalent bioavailability. Meanwhile, personalization trends, driven by AI and genetic insights, are reshaping how parents and practitioners select DHA dosages, with 80% of genetic testing service users valuing tailored nutritional guidance in 2025, underscoring a growing appetite for custom-fit supplementation regimens.

In April 2025, sweeping U.S. tariff measures introduced a 10% global levy on imported goods, accompanied by reciprocal duties targeting countries with significant trade surpluses, profoundly affecting supply chains for active ingredients and finished products in pediatric nutrition. The dietary supplement industry has experienced effective tariff rates ranging from 55% to 70% on core raw materials from China, India, and Japan, prompting trade associations to lobby for exclusions under Section 232 investigations to mitigate cost pressures. Notably, under the Annex II exemptions, DHA and EPA ingredients were specifically spared from the steepest levies, yet ancillary components and packaging materials remain vulnerable, driving manufacturers to diversify sourcing strategies, reevaluate inventory buffers, and engage in advanced duty drawback programs to preserve margin integrity.

Insights into the children’s DHA supplement market reveal nuanced demand drivers across multiple dimensions. Formulations extend beyond traditional softgels, encompassing intensely flavored gummies, palatable powders, liquid syrups, and precision-dosed capsules designed to simplify administration for young age cohorts. Age-specific preferences underscore that preschoolers and school-age children are the most actively supplemented segments, driven by heightened cognitive development priorities among parents. Distribution pathways have broadened from classic brick-and-mortar pharmacies to robust online platforms, including both direct-to-consumer storefronts and third-party e-commerce marketplaces, while chain and independent pharmacies continue to capture health-conscious families seeking professional guidance. Application areas reflect a diversified health profile where cognitive support remains paramount, yet immune system fortification, general wellness maintenance, and vision support are increasingly integral. Packaging variations, from large-count 120-unit bottles for cost efficiency to compact 30- and 60-count formats for trial and portability, as well as segmented powder packs for customizable dosing, further illustrate the market’s maturation and consumer demand for flexible delivery options.

Regional dynamics in the children’s DHA sector are highly differentiated by consumer behavior, regulatory frameworks, and economic development. In the Americas, where approximately one third of U.S. children and adolescents used dietary supplements in 2017–2018, robust e-commerce growth and subscription models have elevated parental access to DHA products via streamlined digital channels. Within Europe, mandatory compositional standards for infant and follow-on formulas enforce inclusion of DHA-and often arachidonic acid-at levels mirroring human milk, complemented by strong consumer demand for plant-based, third-party certified supplements that align with clean-label preferences. Across Asia-Pacific, burgeoning middle-class populations, government nutrition guidelines targeting increased seafood consumption, and the 2025 Food and Nutrition Development Outline in China-which sets a per capita seafood intake target of 29 kilograms by 2030-collectively underscore a trajectory of rapid DHA adoption in infant and complementary feeding products.

Leading stakeholders are advancing multifaceted strategies to capture market share and differentiate offerings. Nordic Naturals has streamlined its Omega-3 portfolio by introducing high-potency children’s softgels and chewables that deliver elevated DHA levels in palatable formats, accompanied by comprehensive transparency initiatives and third-party testing guarantees to reinforce consumer trust. dsm-firmenich, leveraging its Veramaris® brand of algal omega-3, has advocated for legislative support to expand prenatal and early-life DHA access, underscoring the compound’s role in reducing preterm birth risk and underscoring economic value propositions to policymakers. Bioplus Life Sciences’ recent EFSA nod for its proprietary Schizochytrium-derived oil positions it as a top-tier sustainable supplier, while traditional fish oil manufacturers are scaling production to offset supply volatility and capitalize on new marine ingredient yields.

Industry leaders should prioritize proactive supply diversification by integrating algal DHA to mitigate fishery-driven supply risks while preserving traditional marine sources. Strategic engagement with regulatory bodies via targeted policy advocacy will safeguard tariff exemptions and shape favorable duty outcomes. Embracing digital commerce and DTC platforms-bolstered by personalized nutrition solutions anchored in genetic insights-can enhance consumer loyalty and drive premium pricing. R&D investment in child-friendly formulations, including advanced microencapsulation and clean-label delivery systems, will reinforce product differentiation. Finally, fostering collaborative partnerships with healthcare professionals and pediatric associations will amplify clinical endorsements, ensuring DHA supplements are integrated into standard pediatric nutritional guidelines.

This report synthesizes insights drawn from multiple secondary sources, including peer-reviewed clinical meta-analyses, regulatory opinions, and industry news outlets. Publicly available data from IFFO, EFSA, and national health surveys were triangulated with expert commentary sourced from trade publications and regulatory filings. Key market dynamics were validated through discourse analysis of genetic testing adoption trends, policy changes, and supply chain disclosures. Citations from peer-reviewed journals and authoritative news platforms ensure that findings are robust, contextually grounded, and reflective of current developments as of mid-2025.

As the children’s DHA supplement market navigates transformative supply surges, innovative algal alternatives, and complex trade policy landscapes, segment-specific insights and regional nuances will dictate competitive positioning. A convergence of consumer demand for personalization, regulatory mandates on formula composition, and technological advances in formulation underscores the imperative for agile strategies. Companies that adeptly integrate sustainable sourcing, digital commerce, and clinical collaboration will set new benchmarks for market leadership. The future of pediatric DHA supplementation will hinge on balancing reliability of supply with evolving health priorities, fostering a resilient industry capable of meeting the nutritional needs of the next generation.

Elevate your strategic positioning in the rapidly evolving children’s DHA supplement market by securing the full research report and personalized insights through a direct consultation with Ketan Rohom, Associate Director of Sales & Marketing. This comprehensive analysis synthesizes critical market intelligence on transformative innovations, tariff landscapes, segmentation dynamics, regional variances, and competitive profiles. Engage with Ketan Rohom to explore bespoke data packages, custom forecasts, and expert recommendations tailored to your organization’s needs. Leverage this opportunity to gain actionable intelligence that will inform product development, optimize distribution strategies, and fortify your competitive edge. Contact Ketan Rohom to acquire the definitive market research report and unlock the insights necessary to drive growth and innovation in children’s DHA preparations.